Insights

Gathering insights about Ozyme…

Similar companies to Ozyme

Ozyme Tech Stack

Ozyme uses 8 technology products and services including Microsoft Clarity, Webpack, Sage, and more. Explore Ozyme's tech stack below.

Microsoft Clarity
Analytics
Webpack
Development
Sage
Enterprise Resource Planning
Google Fonts API
Font Scripts
Platform.sh
Platform As A Service
reCAPTCHA
Security
Google Tag Manager
Tag Management
Apache HTTP Server
Web Servers

Media & News

eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST
LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 10, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - plans to host a webinar on Thursday, November 13, 2025 at 5:00 PM Eastern Time to discuss its results for the third quarter of 2025. Michael Heltzen, CEO of eXoZymes, will lead the call and will be joined by select members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer session.
Nov 10, 2025 | www.accessnewswire.com
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that CEO, Michael Heltzen, will be on the 'AI's Billion-dollar Bet on Life Sciences: From Drug Discovery to Patient Impact' panel at Beryl Elites' 7th Annual Investment Conference on November 4, 2025, in New York City. eXoZymes has developed a next gen biomanufacturing platform capable of producing highly valuable natural products.
Oct 30, 2025 | www.accessnewswire.com
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 29, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that CEO, Michael Heltzen, will present at the Spartan Capital Securities Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City. Participation by eXoZymes underscores the conference's mission to spotlight innovative companies and emerging market leaders positioned for long-term growth.
Oct 29, 2025 | www.accessnewswire.com
CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 23, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that CEO, Michael Heltzen, will present at the 2025 ThinkEquity Conference on October 30, 2025, at the Mandarin Oriental Hotel in New York City. CEO of eXoZymes, Michael Heltzen, states, "Most investors already know that - compared to the number of dollars invested - synthetic biology unfortunately has very little to show for it because it never scaled commercially.
Oct 23, 2025 | www.accessnewswire.com
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that two of its senior leaders - CCO Damien Perriman and VP of Development, Dr. Paul Opgenorth - have been elected to key roles within the BioMADE Governance Committees. Chief Commercial Officer at eXoZymes, Damien Perriman, states, "Being elected to the BioMADE Leadership Council is both an honor and a responsibility.
Sep 30, 2025 | www.accessnewswire.com
eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today
Management to host earnings call at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - plans to host a webinar at 5:00 PM Eastern Time to provides an update on operations through the fiscal quarter that ended June 30, 2025.
Aug 12, 2025 | www.accessnewswire.com
eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST
LOS ANGELES, CA / ACCESS Newswire / August 7, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - plans to host a webinar on Tuesday, August 12, 2025 at 5:00 PM Eastern Time to discuss its results for the second quarter of 2025. Michael Heltzen, CEO of eXoZymes, will lead the call and will be joined by select members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer session.
Aug 07, 2025 | www.accessnewswire.com

Ozyme's Email Address Formats

Ozyme uses at least 1 format(s):

Ozyme Email Formats	Example	Percentage
FLast@ozyme.fr	JDoe@ozyme.fr	49%
LFirst@ozyme.fr	DJohn@ozyme.fr	1%
First.Last@ozyme.fr	John.Doe@ozyme.fr	1%
FLast@ozyme.fr	JDoe@ozyme.fr	49%

Frequently Asked Questions

Where is Ozyme's headquarters located?

Ozyme's main headquarters is located at 6, Boulevard Georges-Marie Guynemer, ZAC Charles-Renard Bâtiment G Saint-Cyr-l’École, Île-de-France 78210, FR. The company has employees across 1 continents, including Europe.

What is Ozyme's stock symbol?

Ozyme is a publicly traded company; the company's stock symbol is EXOZ.

What is Ozyme's official website and social media links?

Ozyme's official website is ozyme.fr and has social profiles on LinkedIn.

What is Ozyme's SIC code NAICS code?

Ozyme's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ozyme have currently?

As of October 2025, Ozyme has approximately 46 employees across 1 continents, including Europe. Key team members include Directrice Des Ventes: A. P.Consultant Marketing Digital: A. B.Ingenieur Technico Commercial: F. F.. Explore Ozyme's employee directory with LeadIQ.

What industry does Ozyme belong to?

Ozyme operates in the Biotechnology Research industry.

What technology does Ozyme use?

Ozyme's tech stack includes Microsoft ClarityWebpackSageGoogle Fonts APIPlatform.shreCAPTCHAGoogle Tag ManagerApache HTTP Server.

What is Ozyme's email format?

Ozyme's email format typically follows the pattern of FLast@ozyme.fr. Find more Ozyme email formats with LeadIQ.

When was Ozyme founded?

Ozyme was founded in 1984.

Ozyme

Q: What is Ozyme's official website and social media links?

Ozyme's official website is ozyme.fr. Ozyme has social profiles on LinkedIn.

Q: How many employees does Ozyme have currently?

Ozyme has approximately 46 employees.

Q: What technology does Ozyme use?

Ozyme's tech stack includes Google Tag Manager, Oracle, Windows Server, Google Analytics, Google Conversion Tracking.

Biotechnology ResearchFrance11-50 Employees

Spécialiste depuis 1984 de la fourniture de produits de laboratoire pour la Recherche, OZYME sélectionne et propose des produits provenant des plus grands noms de la Biologie Cellulaire, de l’Immunologie et de la Biologie Moléculaire.
OZYME se concentre sur ce qui fait plus que jamais sa force : l'engagement et la compétence des femmes et des hommes qui l’animent. L’équipe d’Ozyme est composée d’une quarantaine de collaborateurs passionnés dont plus de la moitié sont des scientifiques issus des 3èmes cycles universitaires ou d’école d’ingénieurs.

Company Overview

Headquarters: 6, Boulevard Georges-Marie Guynemer, ZAC Charles-Renard Bâtiment G Saint-Cyr-l’École, Île-de-France 78210, FR
Website: ozyme.fr
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: EXOZ
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 1984
Employees: 11-50

Media & News

Funding & Financials

$1M
Ozyme's revenue is estimated to be in the range of $1M

Funding & Financials

$1M
Ozyme's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Ozyme

Bioneer

DNA Script

BioCat GmbH (part of AddLife)

Geneious

Modern Meadow

BioEcho Life Sciences

Ozyme Tech Stack

Media & News

eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST

CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference

CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference

CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference

Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees

eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today

eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST

Ozyme's Email Address Formats

Frequently Asked Questions

Where is Ozyme's headquarters located?

What is Ozyme's stock symbol?

What is Ozyme's official website and social media links?

What is Ozyme's SIC code NAICS code?

How many employees does Ozyme have currently?

What industry does Ozyme belong to?

What technology does Ozyme use?

What is Ozyme's email format?

When was Ozyme founded?

Ozyme

Company Overview

Media & News

eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST

CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference

CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?